Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-28

Clinical Trial Update: Riluzole Augmentation Pilot in Depression (RAPID) Trial [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating riluzole augmentation in major depressive disorder was terminated; results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Riluzole (riluzole)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Major Depressive Disorder | Phase 2 | Status: TERMINATED | Results posted: 2019-08-28